Metrics

  • citations in SCIndeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[]
  • visits in previous 30 days:0
  • full-text downloads in 30 days:0

Contents

article: 7 from 17  
Back back to result list
2015, vol. 143, iss. 1-2, pp. 83-86
Granulomatosis with polyangitis (Wegener's) and central nervous system involvement: Case report
aClinical Center Kragujevac, Internal Clinic
bUniversity of Kragujevac, Faculty of Medical Sciences
cClinical Center Kragujevac, Clinic for Urology, Nephrology and Dialysis

emailsanlusa@ptt.rs
Keywords: Granulomatosis polyangitis (Wegener's); central nervous system; treatment; outcome
Abstract
Introduction Granulomatosis with polyangitis (Wegener's) is an antineutrophil cytoplasmic antibody (PR3-ANCA)-associated vasculitis, which commonly involves the upper and lower respiratory tracts and kidneys. Central nervous system involvement is reported in less than 11%, and rarely present at onset. Case Outline We report the case of a 41-year-old male patient with a high disease activity, large organ involvement, as well as central nervous system manifestations presented at onset. Treatment with intravenous pulse methylprednisolone, followed by the pulsed doses of cyclophosphamide was induced. After 6 months of cyclophosphamide pulse therapy a remission was achieved. Next, azathioprine was used for maintenance during the next 18 months. There were no disease flares during 24-month follow-up. Conclusion Granulomatosis with polyangitis (Wegener's) with large organ involvement, affecting the central nervous system structures require a rapid diagnosis and intensive medication treatment in order to prevent or reduce irreversible damage. Our experience confirms the findings reported in the literature that the severe forms of the disease are associated with increased probability of achieving remission, which reflects increased responsiveness of such patients to immunosuppressant therapy.
References
Bacon, P.A., Moots, R., Exley, A., Luqmani, R., Rasmussen, N. (1995) Vital assessment of vasculitis. Clin Exp Rheumatol, 13, 75-8
Berlit, P. (2010) Diagnosis and treatment of cerebral vasculitis. Therapeutic advances in neurological disorders, 3(1): 29-42
Exley, A.R., Bacon, P.A., Luqmani, R.A., Kitas, G.D., Gordon, C., Savage, C.O., Adu, D. (1997) Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis and rheumatism, 40(2): 371-80
Holle, J.U., Gross, W.L. (2011) Neurological involvement in Wegener's granulomatosis. Current opinion in rheumatology, 23(1): 7-11
Jennette, J.C., Falk, R.J., Bacon, P.A., Basu, N., Cid, M.C., Ferrario, F., Flores-Suarez, L.F., Gross, W.L., Guillevin, L., Hagen, E.C., Hoffman, G.S., Jayne, D.R., Kallenberg, C.G. M., Lamprecht, P., Langford, C.A., Luqmani, R.A., Mahr, A.D., Matteson, E. (2012) 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis & Rheumatism, 65(1): 1-11
Kain, R., Exner, M., Brandes, R., Ziebermayr, R., Cunningham, D., Alderson, C.A., Davidovits, A., Raab, I., Jahn, R., Ashour, O., Spitzauer, S., Sunder-Plassmann, G., Fukuda, M., Klemm, P., Rees, A.J. (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nature medicine, 14(10): 1088-96
Lee, R.W., d`Cruz David, P. (2008) Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis. Drugs, 68(6): 747-70
Mukhtyar, C., Guillevin, L., Cid, M.C., Dasgupta, B., de Groot, K., Gross, W., Hauser, T., Hellmich, B., Jayne, D., Kallenberg, C.G.M., Merkel, P.A., Raspe, H., Salvarani, C., Scott, D.G.I., Stegeman, C., Watts, R., Westman, K., Witter, J., Yazici, H., Luqmani, R. (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Annals of the rheumatic diseases, 68(3): 310-7
Mukhtyar, C., Flossmann, O., Hellmich, B., Bacon, P., Cid, M., Cohen-Tervaert, J.W., Gross, W.L., Guillevin, L., Jayne, D., Mahr, A., Merkel, P.A., Raspe, H., Scott, D., Witter, J., Yazici, H., Luqmani, R.A. (2008) Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Annals of the rheumatic diseases, 67(7): 1004-10
Ntatsaki, E., Watts, R.A., Scott, D.G.I. (2010) Epidemiology of ANCA-associated vasculitis. Rheumatic diseases clinics of North America, 36(3): 447-61
Pomper, M.G., Miller, T.J., Stone, J.H., Tidmore, W.C., Hellmann, D.B. (1999) CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR. American journal of neuroradiology, 20(1): 75-85
Reinhold-Keller, E., de Groot, K., Holl-Ulrich, K., Arlt, A.C., Heller, M., Feller, A.C., Gross, W.L. (2001) Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature. Clinical and experimental rheumatology, 19(5): 541-9
Rihová, Z., Jancová, E., Merta, M., Zabka, J., Rysavá, R., Bartůnková, J., Kolárova, I., Tesar, V. (2004) Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA-associated vasculitis--preliminary single center experience. Prague medical report, 105(1): 64-8
Seror, R., Mahr, A., Ramanoelina, J., Pagnoux, C., Cohen, P., Guillevin, L. (2006) Central nervous system involvement in Wegener granulomatosis. Medicine, 85(1): 54-65
Tumiati, B., Zuccoli, G., Pavone, L., Buzio, C. (2005) ENT Wegener's granulomatosis can hide severe central nervous system involvement. Clinical rheumatology, 24(3): 290-3
 

About

article language: English
document type: Case Report
DOI: 10.2298/SARH1502083T
published in SCIndeks: 19/06/2015

Related records

Vojnosanitetski pregled (2015)
Posterior reversible encephalopathy syndrome: A case report
Kostić Dejan, et al.